A password will be e-mailed to you.

Guest Post by Frank Colombo, Partner and Chief Risk Officer of Aspen Finance LLC Despite solid efforts to reduce cash burn, cannabis companies will require significant amounts of financing in 2020 to complete their build-outs and strategic acquisitions but The equity market is virtually closed to a large swath of cannabis companies. Even those with solid business positions and clear paths to profitability will find selling equity painful at the new price levels. Expect to see a marked increase in distressed asset sales from companies who probably could have sold equity in early 2019. The cannabis crash of 2019 occurred because the growth and margin assumptions required to support earlier valuations were too extreme. Investor expectations regarding growth rates, time to cash positive, stabilized EBITDA margins, costs of capital, and the difficulty of eliminating the illegal market, have been adjusted, and cannabis equities are now more fairly priced. The market may recover a bit from here; however, barring a major catalyst like full federal legalization (which doesn’t seem likely in the near term), those heady IPO/RTO prices are gone for good. The Importance of Cannabis Debt Scoring During the Capital Crunch

thumbnail courtesy of newcannabisventures.com